Literature DB >> 33732146

Anti-High Mobility Group Box-1 Monoclonal Antibody Attenuates Seizure-Induced Cognitive Decline by Suppressing Neuroinflammation in an Adult Zebrafish Model.

Yam Nath Paudel1, Iekhsan Othman1,2, Mohd Farooq Shaikh1.   

Abstract

Epilepsy is a chronic brain disease afflicting around 70 million global population and is characterized by persisting predisposition to generate epileptic seizures. The precise understanding of the etiopathology of seizure generation is still elusive, however, brain inflammation is considered as a major contributor to epileptogenesis. HMGB1 protein being an initiator and crucial contributor of inflammation is known to contribute significantly to seizure generation via activating its principal receptors namely RAGE and TLR4 reflecting a potential therapeutic target. Herein, we evaluated an anti-seizure and memory ameliorating potential of an anti-HMGB1 monoclonal antibody (mAb) (1, 2.5 and 5 mg/kg, I.P.) in a second hit Pentylenetetrazol (PTZ) (80 mg/kg, I.P.) induced seizure model earlier stimulated with Pilocarpine (400 mg/kg, I.P.) in adult zebrafish. Pre-treatment with anti-HMGB1 mAb dose-dependently lowered the second hit PTZ-induced seizure but does not alter the disease progression. Moreover, anti-HMGB1 mAb also attenuated the second hit Pentylenetetrazol induced memory impairment in adult zebrafish as evidenced by an increased inflection ration at 3 and 24 h trail in T-maze test. Besides, decreased level of GABA and an upregulated Glutamate level was observed in the second hit PTZ induced group, which was modulated by pre-treatment with anti-HMGB1 mAb. Inflammatory responses occurred during the progression of seizures as evidenced by upregulated mRNA expression of HMGB1, TLR4, NF-κB, and TNF-α, in a second hit PTZ group, which was in-turn downregulated upon pre-treatment with anti-HMGB1 mAb reflecting its anti-inflammatory potential. Anti-HMGB1 mAb modulates second hit PTZ induced changes in mRNA expression of CREB-1 and NPY. Our findings indicates anti-HMGB1 mAb attenuates second hit PTZ-induced seizures, ameliorates related memory impairment, and downregulates the seizure induced upregulation of inflammatory markers to possibly protect the zebrafish from the incidence of further seizures through via modulation of neuroinflammatory pathway.
Copyright © 2021 Paudel, Othman and Shaikh.

Entities:  

Keywords:  anti-HMGB1 mAb; cognitive decline; epilepsy; neuroinflammation; seizures; zebrafish

Year:  2021        PMID: 33732146      PMCID: PMC7957017          DOI: 10.3389/fphar.2020.613009

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  80 in total

1.  Anti-High Mobility Group Box 1 Antibody Therapy May Prevent Cognitive Dysfunction After Traumatic Brain Injury.

Authors:  Yu Okuma; Hidenori Wake; Kiyoshi Teshigawara; Yu Takahashi; Tomohito Hishikawa; Takao Yasuhara; Shuji Mori; Hideo K Takahashi; Isao Date; Masahiro Nishibori
Journal:  World Neurosurg       Date:  2018-11-02       Impact factor: 2.104

2.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

Review 3.  Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy.

Authors:  Yam Nath Paudel; Mohd Farooq Shaikh; Sadia Shah; Yatinesh Kumari; Iekhsan Othman
Journal:  Eur J Pharmacol       Date:  2018-08-17       Impact factor: 4.432

4.  Tanshinone IIA exhibits anticonvulsant activity in zebrafish and mouse seizure models.

Authors:  Olivia Erin Buenafe; Adriana Orellana-Paucar; Jan Maes; Hao Huang; Xuhui Ying; Wim De Borggraeve; Alexander D Crawford; Walter Luyten; Camila V Esguerra; Peter de Witte
Journal:  ACS Chem Neurosci       Date:  2013-09-06       Impact factor: 4.418

5.  Decreased neuron loss and memory dysfunction in pilocarpine-treated rats pre-exposed to hypoxia.

Authors:  Raquel Araujo Do Val-da Silva; José Eduardo Peixoto-Santos; Renata Caldo Scandiuzzi; Priscila Alves Balista; Mirian Bassi; Mogens Lesner Glass; Rodrigo Neves Romcy-Pereira; Orfa Yineth Galvis-Alonso; João Pereira Leite
Journal:  Neuroscience       Date:  2016-06-29       Impact factor: 3.590

6.  Expressions of tumor necrosis factor alpha and microRNA-155 in immature rat model of status epilepticus and children with mesial temporal lobe epilepsy.

Authors:  Muhammad Usman Ashhab; Ahmed Omran; Huimin Kong; Na Gan; Fang He; Jing Peng; Fei Yin
Journal:  J Mol Neurosci       Date:  2013-05-01       Impact factor: 3.444

7.  Anti-Inflammation Associated Protective Mechanism of Berberine and its Derivatives on Attenuating Pentylenetetrazole-Induced Seizures in Zebrafish.

Authors:  Baoyue Zhang; Lizhen Wang; Xiuna Ji; Shanshan Zhang; Attila Sik; Kechun Liu; Meng Jin
Journal:  J Neuroimmune Pharmacol       Date:  2020-01-06       Impact factor: 4.147

8.  CREB Protects against Temporal Lobe Epilepsy Associated with Cognitive Impairment by Controlling Oxidative Neuronal Damage.

Authors:  Jihong Xing; Dongfeng Han; Dahai Xu; Xingliang Li; Lichao Sun
Journal:  Neurodegener Dis       Date:  2020-05-15       Impact factor: 2.977

9.  Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach.

Authors:  Uday P Kundap; Yatinesh Kumari; Iekhsan Othman; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2017-08-03       Impact factor: 5.810

10.  Embelin Prevents Seizure and Associated Cognitive Impairments in a Pentylenetetrazole-Induced Kindling Zebrafish Model.

Authors:  Uday Praful Kundap; Yam Nath Paudel; Yatinesh Kumari; Iekshan Othman; Mohd Farooq Shaikh
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810

View more
  3 in total

1.  Polydatin Prevents Neuroinflammation and Relieves Depression via Regulating Sirt1/HMGB1/NF-κB Signaling in Mice.

Authors:  Hetao Bian; Ling Xiao; Liang Liang; Yinping Xie; Huiling Wang; Mark Slevin; Wen-Jun Tu; Gaohua Wang
Journal:  Neurotox Res       Date:  2022-08-20       Impact factor: 3.978

Review 2.  Aquatic Freshwater Vertebrate Models of Epilepsy Pathology: Past Discoveries and Future Directions for Therapeutic Discovery.

Authors:  Rachel E Williams; Karen Mruk
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

Review 3.  Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation.

Authors:  Ulf Andersson; Kevin J Tracey; Huan Yang
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.